H.B. Fuller offers discounted exposure to a durable specialty-adhesives moat, with Quantum Leap margins and AMS integration driving upside but leverage and weak volumes keeping risk elevated.
Overview
H.B. Fuller is the world’s largest pure-play specialty-adhesives, sealants, and functional-coatings manufacturer, generating FY2025 revenue of $3.5 billion and net income of $152.0 million across more than 30 end markets and 150 countries. HHCA contributes approximately 45% of revenue, Engineering Adhesives 30%, and BAS 25%. **The core investment case is a durable moat built on qualification barriers, technical formulation, and low customer concentration:** no customer exceeds 10% of sales, retention averages approximately 87%, and the company holds more than 1,400 patents. Q3 FY2026 revenue increased 5.2% to $938.2 million, Adjusted EBITDA rose 9.4% to $186.7 million, margin reached a record 19.9%, and Adjusted EPS increased 20.6% to $1.52 despite a 3.0% volume decline. **Valuation is depressed:** at approximately $49.41, the stock trades at about 10.3x FY2026 Adjusted EPS, 7.2x EV/EBITDA, and 0.80x sales versus a historical 10-year P/E average of 17.5x–18.5x. Near-term catalysts are Quantum Leap savings, AMS integration, debt paydown, and volume recovery; leverage near 4.0x EBITDA remains the central constraint.